CSIMarket
 


Purple Biotech Ltd   (PPBT)
Other Ticker:  
 
 

PPBT's Operating Income Growth by Quarter and Year

Purple Biotech Ltd 's Operating Income results by quarter and year




PPBT Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December -22.60 -17.93 12.61 7.16
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   -22.60 -17.93 12.61 7.16



PPBT Operating Income fourth quarter 2022 Y/Y Growth Comment
Purple Biotech Ltd in the fourth quarter 2022 recorded Operating Loss of $ -22.60 millions.

Looking into fourth quarter 2022 results within Major Pharmaceutical Preparations industry 29 other companies have achieved higher Operating Income growth. While Purple Biotech Ltd ' s Operating Income no change of % ranks overall at the positon no. 1440 in the fourth quarter 2022.

Explain Operating Income growth


PPBT Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - 76.12 % -8.56 %
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - 76.12 % -8.56 %

Financial Statements
Purple Biotech Ltd 's fourth quarter 2022 Operating Income $ -22.60 millions PPBT's Income Statement
Purple Biotech Ltd 's fourth quarter 2021 Operating Income $ -17.93 millions Quarterly PPBT's Income Statement
New: More PPBT's historic Operating Income Growth >>


PPBT Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - 76.12 % -8.56 %




Operating Income fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #30
Healthcare Sector #99
Overall #1440

Operating Income Y/Y Growth Statistics
High Average Low
76.24 % 33.84 % -8.56 %
(Dec 31 2020)  
Operating Income fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #30
Healthcare Sector #99
Overall #1440
Operating Income Y/Y Growth Statistics
High Average Low
76.24 % 33.84 % -8.56 %
(Dec 31 2020)  

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Purple Biotech Ltd 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PPBT's IV. Quarter Q/Q Operating Income Comment


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PPBT's IV. Quarter Q/Q Operating Income Comment


Purple Biotech Ltd 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Jun 30 2019)
Cumulative Operating Income 12 Months Ending $ -22.60 $ -17.93 $ 12.61 $ 7.16 $ 0.00
Y / Y Operating Income Growth (TTM) - - 76.24 % -8.56 % -
Year on Year Operating Income Growth Overall Ranking # 1440 # 0 # 0 # 0 # 0
Seqeuential Operating Income Change (TTM) - - 76.24 % -8.56 % -
Seq. Operating Income Growth (TTM) Overall Ranking # 1440 # 0 # 0 # 0 # 0




Cumulative Operating Income growth Comment
Purple Biotech Ltd ' has realized cumulative trailing twelve months Operating Loss of $ -23 millions in the Dec 31 2022 period.
The situation is detiriorating as the cumulative Operating Loss is getting bigger from $ -17.93 millions in TTM ending quarter Dec 31 2021 and $ 0 millions for the twelve months ending in the quarter a year ago Shanaya Gavde  mentioned.

In the Healthcare sector 98 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 0 to 1440.

Operating Income TTM Q/Q Growth Statistics
High Average Low
76.24 %
33.84 %
-8.56 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 30
Healthcare Sector # 99
Overall # 1440

Operating Income TTM Y/Y Growth Statistics
High Average Low
76.24 %
33.84 %
-8.56 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 30
Sector # 99
S&P 500 # 1440
Cumulative Operating Income growth Comment
Purple Biotech Ltd ' has realized cumulative trailing twelve months Operating Loss of $ -23 millions in the Dec 31 2022 period.
The situation is worsening as the cumulative Operating Loss is inflating from $ -17.93 millions in TTM ending quarter Dec 31 2021 and $ 0 millions for the twelve months ending in the quarter Jun 30 2019 Shanaya Gavde  wrote.

In the Healthcare sector 98 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 0 to 1440.

Operating Income TTM Q/Q Growth Statistics
High Average Low
76.24 %
33.84 %
-8.56 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 30
Healthcare Sector # 99
Overall # 1440

Operating Income TTM Y/Y Growth Statistics
High Average Low
76.24 %
33.84 %
-8.56 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 30
Sector # 99
S&P 500 # 1440




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
PPBT's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for PPBT's Competitors
Operating Income Growth for Purple Biotech Ltd 's Suppliers
Operating Income Growth for PPBT's Customers

You may also want to know
PPBT's Annual Growth Rates PPBT's Profitability Ratios PPBT's Asset Turnover Ratio PPBT's Dividend Growth
PPBT's Roe PPBT's Valuation Ratios PPBT's Financial Strength Ratios PPBT's Dividend Payout Ratio
PPBT's Roa PPBT's Inventory Turnover Ratio PPBT's Growth Rates PPBT's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Dec 31 2022
Scisparc Ltd 43.67%$ 43.672 millions
Medpace Holdings Inc 39.33%$ 39.333 millions
Merit Medical Systems Inc38.92%$ 38.916 millions
Senstar Technologies Ltd 37.28%$ 37.280 millions
Iradimed Corporation36.80%$ 36.799 millions
Carlisle Companies Incorporated34.83%$ 34.834 millions
Pharming Group N v 34.45%$ 34.452 millions
Assertio Holdings inc 33.03%$ 33.029 millions
Repligen Corp30.47%$ 30.469 millions
Biogen Inc 22.11%$ 22.109 millions
Edwards Lifesciences Corporation19.60%$ 19.605 millions
Electromed Inc 18.40%$ 18.401 millions
Inmode Ltd 18.14%$ 18.138 millions
Bio rad Laboratories Inc 17.95%$ 17.945 millions
Vertex Pharmaceuticals Inc17.75%$ 17.748 millions
Avantor Inc 17.66%$ 17.664 millions
Dr Reddys Laboratories Ltd17.17%$ 17.169 millions
Integra Lifesciences Holdings Corp16.52%$ 16.518 millions
Zoetis Inc 16.22%$ 16.216 millions
Alcon inc 15.86%$ 15.862 millions
Check cap Ltd 15.66%$ 15.663 millions
Global Cord Blood Corp15.49%$ 15.491 millions
Idexx Laboratories Inc13.72%$ 13.724 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071